Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Invent Medic Sweden ABXSAT:IMS +7.07% EPS without NRI is kr-0.04 as of Mar. 2026. The stock has 1 warning sign investors should review. Among 663 Medical Devices & Instruments companies, Invent Medic Sweden AB ranks better than 89.44% on this metric.
Invent Medic Sweden AB's earnings per share without non-recurring items for the
three
months ended in Mar. 2026 was kr-0.01.
Its earnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2026 was kr-0.04.
During the past 3 years, the average earnings per share (NRI) Growth Rate was 52.00% per year.
During the past 5 years, the average earnings per share (NRI) Growth Rate was 45.40% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using Earnings per share without Non-Recurring Items (NRI) data.
The historical rank and industry rank for Invent Medic Sweden AB's EPS without NRI or its related term are showing as below:
XSAT:IMS'
s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -35.6 Med: 25 Max: 52
Current: 52
During the past 10 years, Invent Medic Sweden AB's highest 3-Year average Earnings Per Share (NRI) Growth Rate was 52.00% per year. The lowest was -35.60% per year. And the median was 25.00% per year.
XSAT:IMS's 3-Year EPS without NRI Growth Rate is ranked better than 89.44% of 663
companies
in the Medical Devices & Instruments industry
Industry Median: 8
vs XSAT:IMS: 52.00
Invent Medic Sweden AB (XSAT:IMS) EPS without NRI Explanation
EPS without NRI removes onetime and unusual items from EPS, to provide investors with a more accurate measure of the company’s true earnings. The earnings are adjusted for items that are irregular or unusual in nature, and/or are non-recurring. This is calculated using Net Income (Continuing Operations) plus/minus any tax affected unusual Items and Goodwill Impairments/Write Offs. This can be used to fairly measure a company's profitability.
Be Aware
Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.
If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.
Invent Medic Sweden AB EPS without NRI Related Terms
Invent Medic Sweden AB EPS without NRI Historical Data
* Premium members only.
The historical data trend for Invent Medic Sweden AB's EPS without NRI can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XSAT:IMS vs ABT, SYK, MDT: EPS without NRI Comparison
For the Medical Devices subindustry, Invent Medic Sweden AB's PE Ratio without NRI, along with its competitors' market caps and PE Ratio without NRI data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Invent Medic Sweden AB PE Ratio without NRI vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Invent Medic Sweden AB's PE Ratio without NRI distribution charts can be found below:
* The bar in red indicates where Invent Medic Sweden AB's PE Ratio without NRI falls into.
Invent Medic Sweden AB EPS without NRI Calculation
Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.
Earnings Per Share without Non-Recurring Items is the amount of earnings without non-recurring items per outstanding share of the company's stock.
EPS without NRI for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-0.04
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Invent Medic Sweden AB (XSAT:IMS) has a EPS without NRI of kr-0.04 as of Mar. 2026. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on Invent Medic Sweden AB and its competitors. According to the industry distribution chart, Invent Medic Sweden AB ranks #70 out of 663 companies in the Medical Devices & Instruments industry, placing it in the top 10.6%.
Is Invent Medic Sweden AB's EPS without NRI too high?
Invent Medic Sweden AB's current EPS without NRI is kr-0.04. Based on the distribution chart, Invent Medic Sweden AB ranks #70 out of 663 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers.
How does Invent Medic Sweden AB's EPS without NRI compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Invent Medic Sweden AB ranks #70 out of 663 companies for EPS without NRI. This places Invent Medic Sweden AB in the top 11% of its industry — outperforming the majority of peers. The industry median EPS without NRI is 8.00. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS without NRI for a Medical Devices & Instruments company?
The median EPS without NRI among Medical Devices & Instruments companies is 8.00, based on 663 companies in the industry. Companies in the top quartile (top 25%) have a EPS without NRI significantly above this median, while those in the bottom quartile fall well below. However, EPS without NRI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS without NRI mean?
A high EPS without NRI can signal that a stock is expensive relative to its fundamentals. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on Invent Medic Sweden AB and its competitors. For the Medical Devices & Instruments industry, the median EPS without NRI is 8.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Invent Medic Sweden AB's current EPS without NRI is kr-0.04. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Invent Medic Sweden AB stock overvalued right now?
Based on GuruFocus' analysis, Invent Medic Sweden AB (XSAT:IMS) is currently considered Significantly Undervalued. The stock's GF Value™ is kr0.18, compared to a current price of kr0.10 — trading 45.3% below its estimated fair value. The current EPS without NRI is kr-0.04. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS without NRI calculated?
EPS without NRI is calculated from a company's financial statements. For Invent Medic Sweden AB (XSAT:IMS), the current EPS without NRI is kr-0.04 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Invent Medic Sweden AB develops and markets its product - Efemia bladder support, a vaginal medical device for the treatment of female urinary incontinence.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSAT:IMS has been successfully added to your 
